跳至主要内容
临床试验/NCT04164056
NCT04164056招募中4 期

Hippocampal and Thalamic Deep Brain Stimulation for Bilateral Temporal Lobe Epilepsy

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年11月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
Change in Seizure Frequency

研究概览

简要总结

The study aims to compare the safety and effectiveness of deep brain stimulation of the hippocampus and the anterior nucleus of the thalamus for reducing the frequency of seizures in patients with bilateral temporal lobe epilepsy.

详细描述

The outcome of resective surgery for bilateral temporal lobe epilepsy (BTLE) is poor. Neuromodulation such as deep brain stimulation is an alternative therapy for patients with drug-resistant epilepsy, especially for those not suitable for resective surgery. This prospective, randomized, open-label trial aims to compare the effectiveness of deep brain stimulation of the hippocampus and the anterior nucleus of the thalamus for bilateral temporal lobe epilepsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients between 12 to 60 years old.
  • •Bilateral temporal lobe epilepsy patients proved by VEEG or SEEG.
  • •At least 3 seizures per month but not more than 10 seizures per month, and the longest seizure interval is no more than 30 days during the baseline.
  • •Patients failed to at least 3 antiepileptic drugs (AEDs), and are receiving at least 1 AEDs now.
  • •Be able to complete seizure diary.
  • •Agree to participate this study and sign informed consent.

排除标准

  • •Extratemporal lobe epilepsy or with potential extratemporal epileptogenic focus.
  • •Patients with psychogenic non-epileptic seizures.
  • •IQ < 70, or unable to complete the study.
  • •Patients are pregnant or plan for it.
  • •Patients with implanted electrical stimulation medical device.
  • •Patients with other severe neuropsychiatric disorders such as dementia, schizophrenia, or neurodegenerative diseases.
  • •Patients with cerebral lesions which unsuitable for lead implantation.

研究组 & 干预措施

stimulation on the hippocampus

Experimental

deep brain stimulation on the hippocampus

干预措施: deep brain stimulation (Device)

stimulation on the anterior nucleus of the thalamus

Active Comparator

deep brain stimulation on the anterior nucleus of the thalamus

干预措施: deep brain stimulation (Device)

结局指标

主要结局

Change in Seizure Frequency

时间窗: 3 years after DBS

The seizure frequency after DBS compared to the seizure frequency in baseline.

Seizure-Free Rate

时间窗: 3 years after DBS

The rate of patients who achieve seizure free after DBS. Patients don't have seizure for at least 1 year are considered seizure free.

Responder Rate

时间窗: 3 years after DBS

The rate of patients response to DBS, patients have at least 50% decrease in average seizure frequency after DBS are considered as responder.

次要结局

  • Change in Percentage of Seizure-free Days(1 year and 3 years after DBS)
  • Change in the Maximum Length of Seizure Intervals(1 year and 3 years after DBS)
  • Change in GTCS Frequency(1 year and 3 years after DBS)
  • Incidence Rate of Sudden Unexplained Death in Epilepsy (SUDEP)(1 year and 3 years after DBS)
  • Change in Memory(1 year and 3 years after DBS)
  • Change in Cognitive Function(1 year and 3 years after DBS)
  • Change in Depression(1 year and 3 years after DBS)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验